TABLE 3.

Tumor Uptake at 10, 60, and 180 Minutes After Administration of ⁶⁸Ga-Labeled FAPI-04, -21, and -46 to Cancer Patients

Patient with…	FAPI-04		FAPI-21			FAPI-46
	60 min	180 min	10 min	60 min	180 min	10 min	60 min	180 min
Colorectal ca.	3 (4.77 ± 4.27)	3 (3.67 ± 3.41)
Colorectal ca.	8 (5.20 ± 0.73)	8 (4.39 ± 1.19)
Mammary ca	6 (3.98 ± 0.80)	6 (3.40 ± 0.78)
Pancreatic ca.	3 (2.90 ± 0.70)	3 (2.90 ± 0.78)
Ovarian ca.			3 (6.41 ± 1.23)	3 (7.48 ± 1.51)	3 (7.42 ± 1.71)
Ovarian ca.			4 (5.27 ± 1.79)	4 (5.36 ± 1.46)	4 (5.10 ± 1.12)
Colorectal ca.			2 (5.47 ± 1.83)	2 (4.52 ± 1.22)	2 (3.32 ± 1.06)
Colorectal ca.						4 (6.85 ± 1.96)	4 (7.23 ± 2.06)	4 (6.40 ± 1.64)
Mammary ca.						7 (7.73 ± 1.86)	7 (5.97 ± 0.84)	7 (4.44 ± 0.96)
Oropharyngeal ca.						2 (6.01 ± 0.82)	2 (6.77 ± 0.65)	2 (6.31 ± 0.25)
CUP						4 (5.41 ± 2.76)	4 (6.45 ± 4.15)	4 (6.93 ± 4.42)

ca. = cancer; CUP = carcinoma of unknown primary.

Data are number of tumor lesions per patient followed by SUV_mean ± SD in parentheses.